Standard Biotools (LAB) Capital Expenditures Growth (3y) (2013 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.43 Bn | 221.37 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 144.26 Bn | 139.91 Bn | 3.61 Bn | -6.49% |
| 3 | Agilent Technologies | 40.88 Bn | 39.12 Bn | 1.04 Bn | -0.41% |
| 4 | Illumina | 30.92 Bn | 29.75 Bn | 770.00 Mn | -5.23% |
| 5 | Revvity | 13.86 Bn | 12.84 Bn | 416.87 Mn | -7.41% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | -7.83% |
| 7 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn | -2.61% |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn | -13.49% |
| 9 | 10x Genomics | 8.74 Bn | 8.18 Bn | 112.50 Mn | 60.17% |
| 10 | Standard Biotools | 283.04 Mn | -193.68 Mn | 10.54 Mn | -25.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.68% |
| Mar 31, 2026 | -17.36% |
| Dec 31, 2025 | -14.25% |
| Sep 30, 2025 | -11.17% |
| Jun 30, 2025 | 26.24% |
| Mar 31, 2025 | 79.90% |
| Dec 31, 2024 | 89.12% |
| Sep 30, 2024 | -43.94% |
| Jun 30, 2024 | -44.11% |
| Mar 31, 2024 | -51.68% |
| Dec 31, 2023 | -80.61% |
| Sep 30, 2023 | 38.72% |
| Jun 30, 2023 | 9.34% |
| Mar 31, 2023 | -0.65% |
| Dec 31, 2022 | 14.73% |
| Sep 30, 2022 | -2.07% |
| Jun 30, 2022 | 30.82% |
| Mar 31, 2022 | 48.32% |
| Dec 31, 2021 | 192.40% |
| Sep 30, 2021 | 301.35% |